Encephalitis lethargica is a mysterious inflammatory brain disease that causes extreme sleepiness, paralysis of eye movements, and in many cases, a slow progression into a Parkinson’s-like state that can last decades. It swept the world in a pandemic between roughly 1915 and 1925, affecting an estimated 2 to 3 million people and killing about 1 million of them, a mortality rate of approximately 40%. Then it largely vanished, and scientists still don’t fully understand why it appeared or where it went.
The Acute Phase: How It Begins
The illness typically starts with symptoms that look like many other infections: headache, fever, and general fatigue. Within days, though, the disease takes a distinctive turn. Patients develop severe sleep disturbances, either sleeping for extraordinarily long stretches (sometimes days or weeks at a time) or losing the ability to sleep entirely. This profound disruption of the sleep-wake cycle is where the disease gets its name: “lethargica” refers to the deep, trance-like drowsiness that defined many cases.
The other hallmark of the acute phase is paralysis of eye muscles, a condition called ophthalmoplegia. Patients lose the ability to move their eyes normally, sometimes becoming unable to look in certain directions at all. These two features, extreme sleep abnormalities and eye movement paralysis, remain the core diagnostic markers for the disease. Beyond these, acute cases could produce a wide range of neurological and psychiatric symptoms, from involuntary movements to personality changes, making the disease notoriously difficult to recognize in its early stages.
The Chronic Phase: Post-Encephalitic Parkinsonism
For those who survived the acute illness, the ordeal was often far from over. Many patients developed a form of Parkinsonism years or even decades later. The gap between the initial infection and the appearance of Parkinson’s-like symptoms could stretch more than ten years, a delay that puzzled doctors and made the connection difficult to establish at first.
Post-encephalitic Parkinsonism shares some features with typical Parkinson’s disease, including stiffness throughout the body, difficulty initiating movement, postural instability, and speech problems. But it also has distinctive characteristics. The classic resting tremor seen in ordinary Parkinson’s was actually uncommon in post-encephalitic patients. Instead, many experienced oculogyric crises: sudden, involuntary episodes where the eyes lock into an upward or sideways gaze, sometimes for minutes or hours. These episodes were never part of the acute illness itself but became a signature feature of the chronic aftermath.
The progression was remarkably slow. Parkinsonian symptoms in post-encephalitic patients lasted between 17 and 33 years in documented cases. Some patients lived into their 60s and 70s while managing symptoms that had begun decades earlier, their bodies locked in a gradually worsening state of rigidity and immobility.
The 1915–1925 Pandemic
The first recognized cases appeared in Italy around 1915, and by the late 1910s the disease had spread across Europe and beyond. The pandemic overlapped significantly with the 1918 influenza pandemic, and for decades researchers debated whether the two were connected. The timing was striking: between 1917 and 1920 alone, the flu killed more than 20 million people while encephalitis lethargica claimed roughly 1 million lives.
The neurologist Constantin von Economo provided the first detailed clinical description in 1917, documenting the pattern of sleepiness, eye paralysis, and eventual motor decline. Acute cases continued appearing through about 1925, after which the epidemic form of the disease essentially disappeared. Cases of post-encephalitic Parkinsonism, however, continued to be diagnosed through at least 1938, as survivors of the earlier wave developed delayed symptoms. The patients made famous by Oliver Sacks were still living with those consequences in the late 1960s.
What Causes It
Nearly a century after the pandemic, the cause of encephalitis lethargica remains one of neurology’s most frustrating unsolved puzzles. No specific virus was ever isolated from patients during the pandemic, and attempts to identify one from preserved brain tissue have repeatedly come up empty.
The leading theory today combines two ideas. The disease likely began with a viral infection that then triggered an autoimmune response, meaning the immune system, after fighting the initial virus, turned against the brain itself. This would explain why no virus has been found in tissue samples: by the time the brain damage was most severe, the immune system had already cleared the original pathogen. What remained was inflammation driven by the body’s own defenses attacking brain tissue.
This two-stage model, a viral trigger followed by autoimmune destruction, fits both the epidemic pattern of the disease (suggesting something contagious was spreading) and the immunological evidence gathered from more recent cases. But the specific virus responsible has never been identified. Whether it was related to influenza, to some other pathogen circulating at the time, or to something entirely unknown remains an open question.
The “Awakenings” Story
The most widely known chapter in the history of encephalitis lethargica came in 1969, when neurologist Oliver Sacks administered a new drug called levodopa (L-dopa) to a group of post-encephalitic patients at a chronic care hospital in New York. These patients had been frozen in near-motionless states for decades, some since the 1920s.
The initial results were extraordinary. One patient, known as Leonard L., experienced a happiness he said he hadn’t felt in thirty years. Others regained the ability to move, speak, and engage with the world around them after spending most of their lives trapped in rigid bodies. Levodopa was being hailed at the time as a miracle drug for Parkinsonism, and these responses seemed to confirm that promise.
The awakenings didn’t last. Within weeks, many patients developed severe and unpredictable reactions to the drug. Leonard L. became so sensitive that even tiny doses produced uncontrollable side effects. Another patient, Miron V., initially responded well but then became violently unstable. Perhaps most poignantly, a woman known as Rose R., who had contracted sleeping sickness at age 21, woke up in 1969 to discover that her world of 1926 had vanished. She remained psychologically rooted in the 1920s, and as if the decades-long gap was beyond her ability to process, she eventually stopped responding to the medication entirely. Sacks documented these cases in his 1973 book “Awakenings,” later adapted into a film, bringing encephalitis lethargica to public attention for the first time in decades.
Sporadic Cases Today
Although the pandemic ended a century ago, encephalitis lethargica has not entirely disappeared. Sporadic cases matching the original clinical description continue to appear in the medical literature. These are rare, isolated occurrences with no epidemic pattern, and they remain extremely difficult to diagnose. Because the cause was never identified, there is no definitive test for the disease. Doctors must rely on recognizing the characteristic combination of sleep disturbance, eye movement paralysis, and other neurological symptoms while ruling out other forms of encephalitis.
The existence of these modern cases keeps the disease relevant to neurology and raises an uncomfortable possibility: whatever triggered the original pandemic could, in theory, resurface. The COVID-19 pandemic renewed interest in encephalitis lethargica among researchers, partly because it demonstrated how a widespread viral infection can produce delayed neurological complications. Whether COVID-19 could trigger anything resembling encephalitis lethargica remains speculative, but the parallel has pushed new research into understanding how viral infections provoke autoimmune attacks on the brain.